CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jiangsu Cowin Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jiangsu Cowin Biotech Co Ltd
No. 18 Zelan Road
Medical High tech Zone
Phone: +86 52386200880p:+86 52386200880 TAIZHOU, JNG  225311  China Ticker: 688426688426
Business Summary
Jiangsu Cowin Biotech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of molecular detection products. The Company is also in the business of molecular testing services. Molecular detection products include molecular detection raw materials enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The Company's products are exported to the United States, Peru, Germany and other countries and regions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023-----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ChunxiangWang 56 10/1/2020 10/1/2020
Chief Financial Officer, Deputy General Manager FugangLi 47 1/1/2023 1/1/2023
Deputy General Manager, Secretary of the Board, Director YubaiQi 42 10/1/2020 10/1/2020
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 657 (As of 12/31/2023)
Outstanding Shares: 112,493,716 (As of 10/25/2024)
Shareholders: 4,186
Stock Exchange: SHA
Fax Number: +86 52386200880


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024